- Rank
- 601st of 813
- Companies held
- 1
- Largest holding
- RPRX, 100.0% of total
- Latest SEC filing
- Dec 2, 2022
- Listed but not counted
- $1.15B
What the $118M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Royalty Pharma RPRX Class A Ordinary Shares | Through Avara Management Ltd. Reported jointly by 2 insiders; split evenly | 1,738,760 | $67.72 | $118M | 100.0% | Form 4, Dec 1, 2022 |
Share counts are the amounts Skyeline Management Ltd reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Skyeline Management Ltd's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Royalty Pharma RPRX Class A Ordinary Shares | Through Skyeline Management Ltd. Held by a company or fund the insider manages | 9,076,640 | $67.72 | $615M | — | Form 4, Aug 25, 2022 |
| Royalty Pharma RPRX Class A Ordinary Shares | Indirectly (see filing footnote) Held by a company or fund the insider manages | 7,879,374 | $67.72 | $534M | — | Form 4, Dec 2, 2022 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 598 | Prescott General Partners LLC 10% owner, Credit Acceptance | $119M |
| 599 | Insight Venture Partners X (Co-Investors), L.P. Director, nCino | $118M |
| 600 | Narragansett Financial Corp 10% owner, Narragansett Bancorp | $118M |
| 601 | Skyeline Management Ltd 10% owner, Royalty Pharma | $118M |
| 602 | Carlyle Group Inc. 10% owner, Medline | $117M |
| 603 | Tru St Partnership, L.P. 10% owner, Integra LifeSciences Holdings | $115M |
| 604 | Pale Fire Capital SICAV a.s. 10% owner, Groupon | $115M |
Other Royalty Pharma insiders
All RPRX insiders- Pablo G. Legorreta$335MCEO, Chairman of the Board. #516 overall
- George W. Lloyd$184MEVP, Investments & CLO. #939 overall
- Terrance P. Coyne$132MEVP & CFO. #1225 overall
- James F. Reddoch$57.3MEVP & Chief Scientific Officer. #2308 overall
- Rory B. Riggs$28.5MDirector. #2661 overall
- Christopher Hite$13.6MEVP & Chairman, Partnering. #6964 overall
Questions
How much stock does Skyeline Management Ltd own?
Skyeline Management Ltd holds $117,748,827 in listed stock based on SEC filings and current prices, mostly Royalty Pharma (RPRX). That ranks 601st on the Stock Rich List.
Is this Skyeline Management Ltd's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with SEC filer 1814882.